Nutrition Care in Patients With GC: Recommendations During and After…

2nd Annual International Gastric Cancer Educational Symposium

R. Lopez

Optimizing 2/3L Therapy for GE Adenocarcinoma: RAINBOW Paclitaxel/Ra…

UChicago Medicine

D. Catenacci

Optimization of Perioperative Gastric Cancer Care: What Are the Outc…

2nd Annual International Gastric Cancer Educational Symposium

A. Nagarajan

RAINBOW & REGARD Trial Data on Gastric Cancer: The Impact of 2L Ramu…

Afsaneh Barzi

Genetic Testing in Gastric Cancer: How to Recognize Hereditary Cance…

2nd Annual International Gastric Cancer Educational Symposium

S. Rhode

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclita…

2020 ASCO Virtual Direct™ Highlights

D. Catenacci

Gastric Cancer Management: Why Is It Important to Actively Treat? Ho…

Geoffrey Ku

Efficacy Data From RAINBOW Trial on Advanced Gastric Cancer: The Eff…

Zev A. Wainberg

New Standard for 2nd Line Therapy in Metastatic Gastric Cancer: VEGF…

ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer

T. Omrcen

Nutrition Considerations for Gastroesophageal Cancer: Goals, How the…

Gastroesophageal Cancer Educational Symposium

A. Draviam

Managing Hereditary Diffuse Gastric Cancer: Is Prophylactic Gastrect…

2nd Annual International Gastric Cancer Educational Symposium

M. Burch

Integrative Medicine for GC: What Is Integrative Oncology, and How t…

2nd Annual International Gastric Cancer Educational Symposium

M. Cusnir

Targeted and Novel Therapy in HER2+ Advanced Gastric Cancer: Efficac…

Shagufta Shaheen

2021 Update on HER2- Gastric Cancer: 1L Chemo + Nivo, Bemarituzumab …

Shagufta Shaheen

Utilization of ctDNA NGS Analysis in Stage IV Cancers: PANGEA Strate…

Moffitt Cancer Center

D. Catenacci

Pathologist's Perspective on Targeted Therapies in Advanced Gastric …

Raul Gonzalez

Improving Survival in Advanced HER2+/- Gastric Cancer: Considering 2…

Bassel El-Rayes

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…

Fox Chase Cancer Center

N. Vijayvergia

Recent IO Data in GEJ or Gastric Cancers: Are We There Yet?

10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

O. Alese

Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bem…

2021 KUMC Virtual Multidisciplinary Oncology Review

A. Saeed

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

Understanding Genetic and Environmental Risk Factors in Gastroesopha…

Mayo Clinic & DDF Gastroesophageal Cancer Educational Symposium

L. Boardman

ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in Adva…

Massachusetts General Hospital Cancer Center

S. Klempner